Preclinical evaluation of an engineered oncolytic herpes simplex virus for pediatric osteosarcoma.

被引：0
|
作者：
Hutchins, Sara [1 ]
Marayati, Raoud [1 ]
Bownes, Laura V. [1 ]
Quinn, Colin H. [1 ]
Stewart, Jerry E. [1 ]
Friedman, Gregory K. [1 ]
Coleman, Jennifer M. [1 ]
Gillespie, G. Yancey [1 ]
Markert, James M. [1 ]
Beierle, Elizabeth A. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.10040
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10040
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
    Megison, Michael L.
    Gillory, Lauren A.
    Stewart, Jerry E.
    Nabers, Hugh C.
    Mroczek-Musulman, Elizabeth
    Waters, Alicia M.
    Coleman, Jennifer M.
    Kelly, Virginia
    Markert, James M.
    Gillespie, G. Yancey
    Friedman, Gregory K.
    Beierle, Elizabeth A.
    PLOS ONE, 2014, 9 (01):
  • [2] Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
    Gillory, Lauren A.
    Megison, Michael L.
    Stewart, Jerry E.
    Mroczek-Musulman, Elizabeth
    Nabers, Hugh C.
    Waters, Alicia M.
    Kelly, Virginia
    Coleman, Jennifer M.
    Markert, James M.
    Gillespie, G. Yancey
    Friedman, Gregory K.
    Beierle, Elizabeth A.
    PLOS ONE, 2013, 8 (10):
  • [3] Preclinical Safety Evaluation of Oncolytic Herpes Simplex Virus Type 2
    Wang, Yang
    Zhou, Xiaobing
    Wu, Zhen
    Hu, Han
    Jin, Jing
    Hu, Yanping
    Dong, Yuting
    Zou, Jianwen
    Mao, Zeyong
    Shi, Xiaotai
    Huo, Yan
    Lyu, Jianjun
    Fang, Zhizheng
    Zhang, Wen
    Zhu, Yujie
    Li, Bo
    Liu, Binlei
    HUMAN GENE THERAPY, 2019, 30 (05) : 651 - 660
  • [4] Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
    Waters, Alicia M.
    Stafman, Laura L.
    Garner, Evan F.
    Mruthyunjayappa, Smitha
    Stewart, Jerry E.
    Friedman, Gregory K.
    Coleman, Jennifer M.
    Markert, James M.
    Gillespie, G. Yancey
    Beierle, Elizabeth A.
    TRANSLATIONAL ONCOLOGY, 2016, 9 (05): : 419 - 430
  • [5] Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies
    Friedman, Gregory K.
    Pressey, Joseph G.
    Reddy, Alyssa T.
    Markert, James M.
    Gillespie, G. Yancey
    MOLECULAR THERAPY, 2009, 17 (07) : 1125 - 1135
  • [6] Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models
    H Yang
    T Peng
    J Li
    Y Wang
    W Zhang
    P Zhang
    S Peng
    T Du
    Y Li
    Q Yan
    B Liu
    Gene Therapy, 2016, 23 : 450 - 459
  • [7] Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models
    Yang, H.
    Peng, T.
    Li, J.
    Wang, Y.
    Zhang, W.
    Zhang, P.
    Peng, S.
    Du, T.
    Li, Y.
    Yan, Q.
    Liu, B.
    GENE THERAPY, 2016, 23 (05) : 450 - 459
  • [8] Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12
    Markert, James M.
    Cody, James J.
    Parker, Jacqueline N.
    Coleman, Jennifer M.
    Price, Kathleen H.
    Kern, Earl R.
    Quenelle, Debra C.
    Lakeman, Alfred D.
    Schoeb, Trenton R.
    Palmer, Cheryl A.
    Cartner, Samuel C.
    Gillespie, G. Yancey
    Whitley, Richard J.
    JOURNAL OF VIROLOGY, 2012, 86 (09) : 5304 - 5313
  • [9] Oncolytic virus therapy using genetically engineered herpes simplex viruses
    Todo T.
    Human Cell, 2002, 15 (3) : 151 - 159
  • [10] Oncolytic virus therapy using genetically engineered herpes simplex viruses
    Todo, Tomoki
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 2060 - 2064
12345